MedWatch

GN sees progress for troubled US unit

The Danish hearing device giant GN Hearing has experienced Q1 growth rates unseen in years at the US subsidiary Beltone, says chief executive Anders Hedegaard. Beltone is crucial for GN’s growth in the US, estimates senior analyst.

Adm. direktør for GN Hearing
Photo: /ritzau/Stine Bidstrup

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Frontpage right now

FDA vil lette vejen til markedet for medicin mod Alzheimers

De amerikanske lægemiddelmyndigheder vil lempe kravene til godkendelse af lægemidler mod Alzheimers, fordi forskning viser, at sygdommen indtræder tidligere end hidtil antaget. Lægemiddeludviklingen og godkendelse heraf derfor skal tilpasses derefter, mener FDA-boss Scott Gottlieb.

Related articles